Predict your next investment

Cristal Therapeutics company logo
HEALTHCARE | Biotechnology
cristaltherapeutics.com

See what CB Insights has to offer

Stage

Grant - II | Alive

Total Raised

$24.08M

Last Raised

$3M | 4 yrs ago

About Cristal Therapeutics

Cristal Therapeutics, established in Maastricht, focuses on the development of nanomedicines with improved therapeutic efficacy. The pipeline comprises of products based on drugs in development and also on the market, in combination with the patented CriPec platform, for the treatment of various diseases, including cancer and chronic inflammatory disorders. CriPec transforms drugs into polymer nanoparticles via an innovative process. These nanoparticles provide improved distribution throughout the body. The substantial improvement of the efficacy and safety of the drugs entrapped in CriPec nanoparticles has already been demonstrated in animal studies. Cristal Therapeutics has demonstrated the benefits of CriPec for various molecules, including peptide drugs (an anticancer drug transported by a protein that is important for the tumour), as well as for applications such as active targeting for more selective treatment. The results to date have contributed to the company's present innovative product portfolio.

Cristal Therapeutics Headquarter Location

Oxfordlaan 55

Maastricht, 6229 EV,

Netherlands

+31 433 88 58 68

Latest Cristal Therapeutics News

Nanomedicines Market Estimated to Experience a Hike in Growth by 2027 By AstraZeneca ,Cristal Therapeutics ,Ablynx (A Subsidiary Of Sanofi Company) ,BlueWillow Biologics

Mar 30, 2021

Nanomedicines Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, and Vaccines); Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Other Applications); Type (Nanoparticles, Nanoshells, Nanotubes, and Nanodevices), and Geography By SMN Bureau   The proposed Nanomedicines Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The Nanomedicines Market sample report includes an exclusive analysis of COVID-19 pandemic on the market space under scrutiny. The sample represents the format of the overall study which is designed to provide clarity on the structure of the report and some data points demonstrated in an attempt to provide insights into the study quality. Furthermore, the Nanomedicines Market full research study is designed on account of the fact that each segment is individually assessed and then collated to form the whole market, the study can be tailor-made to fit your exact requirements. Request Sample Pages of this research study at –  https://www.theinsightpartners.com/sample/TIPRE00004589/   The structure of the Nanomedicines Market report can be categorized into following sections: Section 1: Scope of the Report & Research Methodology Section 2: Key Takeaways Section 3: Market variables & their impact on growth and analytical tools providing High Level Insights into the Market Dynamics and Growth Pattern Section 4: Market Estimates and Forecasts (with the base year as 2019, historic information of 2016 & 2018 and forecast from 2020 to 2027). Regional and Country Level Estimates and Forecasts for each category which are summed up to form the Global Market. Section 5: Competitive Landscape. Attributes such as Strategy Framework, Competitor Categorization are included to provide elaborate details on the Market Structure & Strategic Undertakings as well as their impact. The Prominent/Emerging Players in the Nanomedicines Market Research include: AstraZeneca BlueWillow Biologics Taiwan Liposome Company, Ltd. The Nanomedicines Market Company Profiles are individually represented for all major participants and indices such as Financial Performance, Strategic Initiatives, Product Portfolio & Company Overview. Company Overview: Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas. Financial Performance: Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title “Financial Performance” (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (SBUs) and others. Product Benchmarking: Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features. Strategic Initiatives: Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section. Order a copy of this research study at –  https://www.theinsightpartners.com/buy/TIPRE00004589/ The Nanomedicines Market research study is designed keeping in focus all the major countries. Although, all these countries & their market trends were accounted for while composing it, detailed sections are available for only the spearheads. In case if you would be interested in specific countries which are not covered in the current scope, kindly share the list & we can customize the study based on the geographical scope defined by you. ABOUT US: The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis. Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc. ; which helps our clients to get a deeper analysis on various research topics. Contact US: North America:          +1 646 491 9876 Asia-Pacific:               +91 20 6727 8686 Email:                        sales@theinsightpartners.com

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cristal Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cristal Therapeutics is included in 5 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharmaceuticals

13,989 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

N

Nanobiotechnology

707 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Cristal Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cristal Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.